Sliding doors.
Remember April last year when SUD raised $1.5m to conduct a proof of concept trial for stiffymist. All they had to do was copy the trial that had been run by IX Biopharma for its sublingual version of Viagra.
And with successful results – lodge their TGA application.
And then one day, just like today, get the happy news that the application had been approved.
Bingo … you now have Australia’s first sublingual version of Viagra. And the timing is perfect because Australia is considering moving Viagra to OTC.
Share price for SUD today … 1c to 10c. Or better.
Plenty of back slapping on this forum. And a few posters here lining up at the chemists for a few sample wafers … for investment research purposes only of-course. Venues would be being discussed for $1 share price SUD golf day.
But its IX Biopharma we are talking about … not SUD.
SUD has even managed to become depressing for a downramper.
http://infopub.sgx.com/FileOpen/Press Release_Wafesil TGA Approval.ashx?App=Announcement&FileID=511190
Sliding doors. Remember April last year when SUD raised $1.5m to...
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.010(5.71%) |
Mkt cap ! $173.4M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.8¢ | 16.5¢ | $500.8K | 2.930M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1061663 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 92438 | 5 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| ALA (ASX) Chart |